ADVERTISEMENT
By
Diagnostics firms should still get fair valuation in IPOs: Thyrocare’s Velumani
Arokiaswamy Velumani

Thyrocare Technologies Ltd had made a spectacular debut on the stock exchanges two years ago. But its share prices have fallen from the highs, prompting the diagnostics company to buy the stock back ...

TO READ THE FULL STORY


Leave Your Comment(s)
OPEN APP